Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
cerebral infarction
MeSH D002544 - cerebral infarction
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D020520:
Brain infarction
0 Companies
0 Drugs
Success rate
D002544:
Cerebral infarction
37 Companies
5 Drugs
$
Success rate
D015161:
Multi-infarct dementia
0 Companies
0 Drugs
Success rate
D020243:
Anterior cerebral artery infarction
0 Companies
0 Drugs
Success rate
D020244:
Middle cerebral artery infarction
0 Companies
0 Drugs
Success rate
D020762:
Posterior cerebral artery infarction
0 Companies
0 Drugs
Success rate
D046589:
Cadasil
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
100
%
3/3
Phase 2
40
%
4/10
Phase 3
40
%
6/15
Approved:
2
Overall Success rate:
16%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Organon
Heparin
,
Heparin sodium
Novartis
Dihydroergotamine
,
Heparin
,
Heparin sodium
,
Lidocaine
Sanofi
Heparin
,
Heparin sodium
Pfizer
Heparin
,
Heparin sodium
Eli Lilly
Heparin
,
Heparin sodium
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use